Meitav Dash Investments LTD Vbi Vaccines Inc Transaction History

Meitav Dash Investments LTD

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 14, 2019	SELL	$0.47 - $1.05 $312,726 - $698,643	-665,375 Closed	0 $0
Q2 2019 Aug 14, 2019	SELL	$0.65 - $2.12 $3,900 - $12,720	-6,000 Reduced 0.89%	665,375 $776,000
Q1 2019 May 13, 2019	SELL	$1.54 - $2.01 $914,760 - $1.19 Million	-594,000 Reduced 46.94%	671,375 $1.26 Million
Q4 2018 Feb 13, 2019	SELL	$1.22 - $2.41 $5,454 - $10,775	-4,471 Reduced 0.35%	1,265,375 $2.03 Million
Q2 2018 Aug 14, 2018	BUY	$2.75 - $3.85 $488,537 - $683,952	177,650 Added 16.27%	1,269,846 $3.82 Million
Q4 2017 Feb 15, 2018	BUY	$3.29 - $5.03 $3.59 Million - $5.49 Million	1,092,196	1,092,196 $4.66 Million

688K

Ticker VBIV
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 258,256,992
Market Cap $5.17M
Description
VBI Vaccines Inc., a biopharmaceutical company, develops and sells vaccines for the treatment of infectious diseases and immuno-oncology. The company offers Sci-B-Vac, a prophylactic hepatitis B (HBV) vaccine. It also engages in the development of VBI-2601 (BRII-179), an immunotherapeutic candidate for the treatment of chronic HBV infection. The...

Get notified when there are updates to the investment portfolio of Meitav Dash Investments LTD, based on Form 13F filings with the SEC.

Stay updated on Meitav Dash Investments LTD with notifications on news.